Trileptal Anti-Seizure Drug Linked with Life-Threatening Side Effects
Trileptal (oxcarbazepine) is the brand name for an anti-seizure medication developed by multinational pharmaceutical giant Novartis International AG. Trileptal is often prescribed for the treatment of bipolar disorder and epilepsy, though it may also be prescribed for “off label” uses that have not been approved by the FDA.
Common Trileptal Side Effects
There are a number of common side effects associated with the use of Trileptal, some of which include:
- Impaired vision
- Electrolyte disturbances (hyponatremia)
- Dry mouth
If any of the aforementioned Trileptal side effects worsen or persist, you are advised to contact your doctor immediately.
Beginning in 2005, the FDA began to take notice of some serious Trileptal side effects that patients and doctors were unaware of. Novartis took little notice of these claims, maintaining that Trileptal was both safe and effective.
Trileptal Side Effects: Steven Johnson Syndrome & Multi-Organ Hypersensitivity
Reports have linked an adverse reaction to the use of Trileptal with the development of a serious skin disorder called Steven Johnson Syndrome (SJS). Stevens Johnson Syndrome is an immune-complex-mediated hypersensitivity condition, meaning that it is caused as a result of an allergic or adverse reaction.
There are a number of anti-convulsants (like Trileptal), antibiotics and pain relievers that can cause SJS. Such drugs can trigger an allergic reaction that causes inflammation of the skin and mucous membranes. Multi-organ hypersensitivity is a related byproduct of SJS because mucous membranes are present in many of the body’s organs. If you develop a severe case of SJS, it can potentially affect multiple organs and organ systems.
There is no curable treatment available for SJS, though palliative treatments can provide relief for your painful and debilitating symptoms. Severe cases of SJS can be fatal. In fact, an estimated 15% of all SJS patients die as a result of the disease.
Novartis Accused of Negligence
Novartis has been accused of negligence for failure to adequately inform consumers and doctors about the risks associated with the use of Trileptal. Lawsuits filed against Novartis allege that the pharmaceutical company willfully concealed information about Trileptal side effects from consumers and doctors. The Switzerland-based company has also been accused of failing to conduct adequate post-marketing analyses of Trileptal that may have discovered the link between the anti-seizure drug and SJS.
This is the latest blow to a company already besieged by personal injury lawsuits related to its irritable bowel syndrome (IBS) drug, Zelnorm, and more than 285 pending lawsuits related to its bone density drugs, Zometa and Aredia.
If you or a loved one has been injured as a result of a using Trileptal, you may be entitled to receive personal injury compensation for your pain and suffering. Drug manufacturers are required by law to ensure that their products are safe and effective before introducing them to the marketplace. Failure to adequately inform consumers of the risks associated with use of their drugs can be viewed as negligent and grounds for pharmaceutical litigation.
The Pensacola personal injury attorneys of Aylstock, Witkin Kreis & Overholtz handle national litigation across the United States for victims injured by defective pharmaceuticals and medical devices. Contact the lawyers of Aylstock, Witkin, Kreis & Overholtz today at (877) 810 4808 to learn more about your rights as a Trileptal injury victim.